C. Persu

557 total citations
26 papers, 387 citations indexed

About

C. Persu is a scholar working on Urology, Rheumatology and Surgery. According to data from OpenAlex, C. Persu has authored 26 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Urology, 10 papers in Rheumatology and 9 papers in Surgery. Recurrent topics in C. Persu's work include Urinary Bladder and Prostate Research (14 papers), Pelvic floor disorders treatments (10 papers) and Bladder and Urothelial Cancer Treatments (6 papers). C. Persu is often cited by papers focused on Urinary Bladder and Prostate Research (14 papers), Pelvic floor disorders treatments (10 papers) and Bladder and Urothelial Cancer Treatments (6 papers). C. Persu collaborates with scholars based in Romania, United States and Argentina. C. Persu's co-authors include P. Geavlete, Christopher R. Chapple, John P. Lavelle, D. Georgescu, Victor Cauni, Nancy Martin, Camilla Tøndel, Elena Albu, Achim Steup and Christopher Lademacher and has published in prestigious journals such as Neurourology and Urodynamics, International Journal of Impotence Research and Life.

In The Last Decade

C. Persu

25 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Persu Romania 9 261 215 122 51 50 26 387
Fei‐Chi Chuang Taiwan 13 339 1.3× 255 1.2× 249 2.0× 42 0.8× 137 2.7× 37 531
Richard P. Santarosa United States 10 275 1.1× 155 0.7× 327 2.7× 109 2.1× 47 0.9× 16 490
Stanley Flax Canada 7 171 0.7× 91 0.4× 159 1.3× 187 3.7× 30 0.6× 10 341
Matteo Giglio Italy 8 104 0.4× 182 0.8× 191 1.6× 71 1.4× 14 0.3× 18 359
Eric Chieh‐Lung Chou Taiwan 11 224 0.9× 91 0.4× 253 2.1× 32 0.6× 110 2.2× 37 360
İbrahim Karam France 9 158 0.6× 174 0.8× 180 1.5× 112 2.2× 9 0.2× 13 359
Else Brohm Kallestrup Denmark 8 107 0.4× 171 0.8× 234 1.9× 25 0.5× 88 1.8× 9 332
Bülent Çeti̇nel Türkiye 11 190 0.7× 104 0.5× 188 1.5× 23 0.5× 81 1.6× 22 306
Nurullah Hamidi Türkiye 11 69 0.3× 103 0.5× 81 0.7× 117 2.3× 11 0.2× 52 292
Alex T.L. Lin Taiwan 9 135 0.5× 96 0.4× 210 1.7× 110 2.2× 16 0.3× 22 383

Countries citing papers authored by C. Persu

Since Specialization
Citations

This map shows the geographic impact of C. Persu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Persu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Persu more than expected).

Fields of papers citing papers by C. Persu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Persu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Persu. The network helps show where C. Persu may publish in the future.

Co-authorship network of co-authors of C. Persu

This figure shows the co-authorship network connecting the top 25 collaborators of C. Persu. A scholar is included among the top collaborators of C. Persu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Persu. C. Persu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mihai, Bogdan, et al.. (2023). Single-Center Experience with Swiss LithoClast® Trilogy for Kidney Stones. Diagnostics. 13(8). 1372–1372. 2 indexed citations
2.
3.
Streinu‐Cercel, Adrian, et al.. (2023). A Novel Risk Calculator to Predict Erectile Dysfunction in HIV-Positive Men. Journal of Personalized Medicine. 13(4). 679–679. 5 indexed citations
4.
Mihai, Bogdan, et al.. (2023). Mini-Perc for Renal Stones—A Single Center Experience and Literature Review. Diagnostics. 13(6). 1083–1083. 1 indexed citations
5.
6.
Wilson, Steven K., Eric Chung, Brian T. Langford, et al.. (2023). First safety outcomes for rigicon conticlassic® artificial urinary sphincter. International Journal of Impotence Research. 36(8). 829–832. 4 indexed citations
7.
Cauni, Victor, et al.. (2021). Magnetic resonance/ultrasound fusion targeted biopsy of the prostate can be improved by adding systematic biopsy. Medical Ultrasonography. 23(3). 277–282. 8 indexed citations
8.
Persu, C., et al.. (2021). Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open‐label, phase 3, dose‐titration study. Neurourology and Urodynamics. 40(6). 1490–1499. 19 indexed citations
9.
Persu, C., et al.. (2015). Combination therapy using solifenacin and mirabegron for OAB patients. European Urology Supplements. 14(6). e1250–e1250. 1 indexed citations
10.
11.
Persu, C., et al.. (2014). A review of prospective Clinical Trials for neurogenic bladder: Pharmaceuticals. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 67(3). 264–9. 8 indexed citations
12.
Persu, C., et al.. (2014). A review of prospective Clinical Trials for neurogenic bladder: The place of surgery, experimental techniques and devices. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 67(3). 270–6. 10 indexed citations
13.
Persu, C.. (2014). 300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 67(1). 41–2. 1 indexed citations
14.
Persu, C., et al.. (2012). The Place of the Ice Water Test (IWT) in the Evaluation of the Patients with Traumatic Spinal Cord Injury.. Europe PMC (PubMed Central). 2 indexed citations
15.
Georgescu, D., et al.. (2012). Prognostic factors in laser treatment of upper urinary tract urothelial tumours.. PubMed. 5(1). 33–8. 10 indexed citations
16.
Persu, C. & P. Geavlete. (2012). 469 Double dose of solifenacin for the treatment of neurogenic detrusor overactivity. European Urology Supplements. 11(1). e469–e469a. 1 indexed citations
17.
Persu, C., et al.. (2010). TURP for BPH. How large is too large. Journal of Medicine and Life. 3(4). 376–380. 21 indexed citations
18.
Persu, C., et al.. (2010). C24 TURP FOR PROSTATES OVER 80ML. HOW LARGE IS TOOLARGE?. European Urology Supplements. 9(6). 625–625. 1 indexed citations
19.
Persu, C., et al.. (2010). From interstitial cystitis to chronic pelvic pain.. PubMed. 3(2). 167–74. 17 indexed citations
20.
Persu, C., et al.. (2010). Diagnosis and treatment of erectile dysfunction--a practical update.. Journal of Medicine and Life. 2(4). 394–400. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fei‐Chi Chuang Breakdown of academic impact, for papers by Richard P. Santarosa Breakdown of academic impact, for papers by Stanley Flax Breakdown of academic impact, for papers by Matteo Giglio Breakdown of academic impact, for papers by Eric Chieh‐Lung Chou Breakdown of academic impact, for papers by İbrahim Karam Breakdown of academic impact, for papers by Else Brohm Kallestrup Breakdown of academic impact, for papers by Bülent Çeti̇nel Breakdown of academic impact, for papers by Nurullah Hamidi Breakdown of academic impact, for papers by Alex T.L. Lin
Rankless by CCL
2026